Between Dec 19, 2024 and Jan 2, 2025, datasets can be submitted to DRUM but will not be processed until after the break. Staff will not be available to answer email during this period, and will not be able to provide DOIs until after Jan 2. If you are in need of a DOI during this period, consider Dryad or OpenICPSR. Submission responses to the UDC may also be delayed during this time.

Browsing by Subject "monoamine oxidase"

Now showing 1 - 1 of 1
  • Thumbnail Image
    Item
    Methamphetamine, Neurodegeneration, and Differential Vulnerability of Dopamine Neurons
    (2021-07) Lee, You Bin
    Methamphetamine (meth) is an addictive and neurotoxic psychostimulant. Meth increases monoamine oxidase (MAO)-dependent axonal mitochondrial stress in substantia nigra pars compacta (SNc) dopamine (DA) neurons and chronic meth administration causes MAO-dependent SNc degeneration. Ventral tegmental area (VTA) neurons also express and utilize MAO to metabolize DA. The current study examined whether VTA neurons are vulnerable or resistant to chronic meth-induced degeneration and underlying mechanisms. We found that, similar to findings in SNc axons, meth induced MAO-dependent mitochondrial stress in VTA axons; however, the VTA was resistant to chronic meth-induced degeneration. The differentiating feature between SNc and VTA neurons was that SNc axons also had L-type Ca2+ channel (LCC)-dependent mitochondrial stress whereas VTA neurons did not. Both MAO and LCC inhibition attenuated meth-induced degeneration of SNc neurons as did a mitochondrial antioxidant. Together these data suggest that both MAO- and LCC-dependent mitochondrial stress are necessary for meth-induced degeneration.